Pharma & Healthcare
Global Oral Vaccines Market Research Report 2024
- Jan 26, 24
- ID: 39316
- Pages: 103
- Figures: 228
- Views: 18
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
The global Oral Vaccines market was valued at US$ 2474 million in 2023 and is anticipated to reach US$ 3333.6 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
This report aims to provide a comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccines.
Report Scope
The Oral Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Segment by Application
Public
Private
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Oral Vaccines market was valued at US$ 2474 million in 2023 and is anticipated to reach US$ 3333.6 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The classification of oral vaccines includes rotavirus vaccine, cholera vaccine, oral polio vaccine and other types, and the sales proportion of polio vaccine is about 94%.
Middle East and Africa is the largest consumption place, with a consumption market share nearly 54%. Following Middle East and Africa, Asia-Pacific is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Merck, GSK and Sanofi, etc. are the leaders of the industry, with about 78% market shares.
This report aims to provide a comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccines.
Report Scope
The Oral Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
GSK
Sanofi
Lanzhou Institute
Serum Institute
Valneva
Shanghai United Cell
Bibcol
PaxVax
Vabiotech
Tiantan Biological
EuBiologics
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Segment by Type
Rotavirus Vaccine
Cholera Vaccine
Oral Polio Vaccine
Segment by Application
Public
Private
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Oral Vaccines Market Overview
1.1 Product Overview and Scope of Oral Vaccines
1.2 Oral Vaccines Segment by Type
1.2.1 Global Oral Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.3 Oral Vaccines Segment by Application
1.3.1 Global Oral Vaccines Market Value by Application: (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Oral Vaccines Market Size Estimates and Forecasts
1.4.1 Global Oral Vaccines Revenue 2019-2030
1.4.2 Global Oral Vaccines Sales 2019-2030
1.4.3 Global Oral Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Vaccines Market Competition by Manufacturers
2.1 Global Oral Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Oral Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Vaccines, Product Type & Application
2.7 Oral Vaccines Market Competitive Situation and Trends
2.7.1 Oral Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Vaccines Players Market Share by Revenue
2.7.3 Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Vaccines Retrospective Market Scenario by Region
3.1 Global Oral Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Vaccines Global Oral Vaccines Sales by Region: 2019-2030
3.2.1 Global Oral Vaccines Sales by Region: 2019-2024
3.2.2 Global Oral Vaccines Sales by Region: 2025-2030
3.3 Global Oral Vaccines Global Oral Vaccines Revenue by Region: 2019-2030
3.3.1 Global Oral Vaccines Revenue by Region: 2019-2024
3.3.2 Global Oral Vaccines Revenue by Region: 2025-2030
3.4 North America Oral Vaccines Market Facts & Figures by Country
3.4.1 North America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Vaccines Sales by Country (2019-2030)
3.4.3 North America Oral Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Vaccines Market Facts & Figures by Country
3.5.1 Europe Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Vaccines Sales by Country (2019-2030)
3.5.3 Europe Oral Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Vaccines Market Facts & Figures by Country
3.7.1 Latin America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Oral Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oral Vaccines Sales by Type (2019-2030)
4.1.1 Global Oral Vaccines Sales by Type (2019-2024)
4.1.2 Global Oral Vaccines Sales by Type (2025-2030)
4.1.3 Global Oral Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Oral Vaccines Revenue by Type (2019-2030)
4.2.1 Global Oral Vaccines Revenue by Type (2019-2024)
4.2.2 Global Oral Vaccines Revenue by Type (2025-2030)
4.2.3 Global Oral Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Oral Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Vaccines Sales by Application (2019-2030)
5.1.1 Global Oral Vaccines Sales by Application (2019-2024)
5.1.2 Global Oral Vaccines Sales by Application (2025-2030)
5.1.3 Global Oral Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Oral Vaccines Revenue by Application (2019-2030)
5.2.1 Global Oral Vaccines Revenue by Application (2019-2024)
5.2.2 Global Oral Vaccines Revenue by Application (2025-2030)
5.2.3 Global Oral Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Oral Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Oral Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Oral Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Oral Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Lanzhou Institute
6.4.1 Lanzhou Institute Corporation Information
6.4.2 Lanzhou Institute Description and Business Overview
6.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
6.4.5 Lanzhou Institute Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Corporation Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute Oral Vaccines Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 Valneva
6.6.1 Valneva Corporation Information
6.6.2 Valneva Description and Business Overview
6.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Valneva Oral Vaccines Product Portfolio
6.6.5 Valneva Recent Developments/Updates
6.7 Shanghai United Cell
6.6.1 Shanghai United Cell Corporation Information
6.6.2 Shanghai United Cell Description and Business Overview
6.6.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai United Cell Oral Vaccines Product Portfolio
6.7.5 Shanghai United Cell Recent Developments/Updates
6.8 Bibcol
6.8.1 Bibcol Corporation Information
6.8.2 Bibcol Description and Business Overview
6.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bibcol Oral Vaccines Product Portfolio
6.8.5 Bibcol Recent Developments/Updates
6.9 PaxVax
6.9.1 PaxVax Corporation Information
6.9.2 PaxVax Description and Business Overview
6.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 PaxVax Oral Vaccines Product Portfolio
6.9.5 PaxVax Recent Developments/Updates
6.10 Vabiotech
6.10.1 Vabiotech Corporation Information
6.10.2 Vabiotech Description and Business Overview
6.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Vabiotech Oral Vaccines Product Portfolio
6.10.5 Vabiotech Recent Developments/Updates
6.11 Tiantan Biological
6.11.1 Tiantan Biological Corporation Information
6.11.2 Tiantan Biological Oral Vaccines Description and Business Overview
6.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Tiantan Biological Oral Vaccines Product Portfolio
6.11.5 Tiantan Biological Recent Developments/Updates
6.12 EuBiologics
6.12.1 EuBiologics Corporation Information
6.12.2 EuBiologics Oral Vaccines Description and Business Overview
6.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 EuBiologics Oral Vaccines Product Portfolio
6.12.5 EuBiologics Recent Developments/Updates
6.13 Panacea Biotec Ltd
6.13.1 Panacea Biotec Ltd Corporation Information
6.13.2 Panacea Biotec Ltd Oral Vaccines Description and Business Overview
6.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
6.13.5 Panacea Biotec Ltd Recent Developments/Updates
6.14 Bio-Med
6.14.1 Bio-Med Corporation Information
6.14.2 Bio-Med Oral Vaccines Description and Business Overview
6.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bio-Med Oral Vaccines Product Portfolio
6.14.5 Bio-Med Recent Developments/Updates
6.15 Halfkin Bio-Pharmaceuticals
6.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Description and Business Overview
6.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Vaccines Industry Chain Analysis
7.2 Oral Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Vaccines Production Mode & Process
7.4 Oral Vaccines Sales and Marketing
7.4.1 Oral Vaccines Sales Channels
7.4.2 Oral Vaccines Distributors
7.5 Oral Vaccines Customers
8 Oral Vaccines Market Dynamics
8.1 Oral Vaccines Industry Trends
8.2 Oral Vaccines Market Drivers
8.3 Oral Vaccines Market Challenges
8.4 Oral Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Oral Vaccines
1.2 Oral Vaccines Segment by Type
1.2.1 Global Oral Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Rotavirus Vaccine
1.2.3 Cholera Vaccine
1.2.4 Oral Polio Vaccine
1.3 Oral Vaccines Segment by Application
1.3.1 Global Oral Vaccines Market Value by Application: (2024-2030)
1.3.2 Public
1.3.3 Private
1.4 Global Oral Vaccines Market Size Estimates and Forecasts
1.4.1 Global Oral Vaccines Revenue 2019-2030
1.4.2 Global Oral Vaccines Sales 2019-2030
1.4.3 Global Oral Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Oral Vaccines Market Competition by Manufacturers
2.1 Global Oral Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Oral Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Oral Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Oral Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Vaccines, Product Type & Application
2.7 Oral Vaccines Market Competitive Situation and Trends
2.7.1 Oral Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Oral Vaccines Players Market Share by Revenue
2.7.3 Global Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Oral Vaccines Retrospective Market Scenario by Region
3.1 Global Oral Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Oral Vaccines Global Oral Vaccines Sales by Region: 2019-2030
3.2.1 Global Oral Vaccines Sales by Region: 2019-2024
3.2.2 Global Oral Vaccines Sales by Region: 2025-2030
3.3 Global Oral Vaccines Global Oral Vaccines Revenue by Region: 2019-2030
3.3.1 Global Oral Vaccines Revenue by Region: 2019-2024
3.3.2 Global Oral Vaccines Revenue by Region: 2025-2030
3.4 North America Oral Vaccines Market Facts & Figures by Country
3.4.1 North America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Oral Vaccines Sales by Country (2019-2030)
3.4.3 North America Oral Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Oral Vaccines Market Facts & Figures by Country
3.5.1 Europe Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Oral Vaccines Sales by Country (2019-2030)
3.5.3 Europe Oral Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Oral Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Oral Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Oral Vaccines Market Facts & Figures by Country
3.7.1 Latin America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Oral Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Oral Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Oral Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Oral Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Oral Vaccines Sales by Type (2019-2030)
4.1.1 Global Oral Vaccines Sales by Type (2019-2024)
4.1.2 Global Oral Vaccines Sales by Type (2025-2030)
4.1.3 Global Oral Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Oral Vaccines Revenue by Type (2019-2030)
4.2.1 Global Oral Vaccines Revenue by Type (2019-2024)
4.2.2 Global Oral Vaccines Revenue by Type (2025-2030)
4.2.3 Global Oral Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Oral Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Oral Vaccines Sales by Application (2019-2030)
5.1.1 Global Oral Vaccines Sales by Application (2019-2024)
5.1.2 Global Oral Vaccines Sales by Application (2025-2030)
5.1.3 Global Oral Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Oral Vaccines Revenue by Application (2019-2030)
5.2.1 Global Oral Vaccines Revenue by Application (2019-2024)
5.2.2 Global Oral Vaccines Revenue by Application (2025-2030)
5.2.3 Global Oral Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Oral Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Oral Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Oral Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Oral Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Lanzhou Institute
6.4.1 Lanzhou Institute Corporation Information
6.4.2 Lanzhou Institute Description and Business Overview
6.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
6.4.5 Lanzhou Institute Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Corporation Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute Oral Vaccines Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 Valneva
6.6.1 Valneva Corporation Information
6.6.2 Valneva Description and Business Overview
6.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Valneva Oral Vaccines Product Portfolio
6.6.5 Valneva Recent Developments/Updates
6.7 Shanghai United Cell
6.6.1 Shanghai United Cell Corporation Information
6.6.2 Shanghai United Cell Description and Business Overview
6.6.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Shanghai United Cell Oral Vaccines Product Portfolio
6.7.5 Shanghai United Cell Recent Developments/Updates
6.8 Bibcol
6.8.1 Bibcol Corporation Information
6.8.2 Bibcol Description and Business Overview
6.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bibcol Oral Vaccines Product Portfolio
6.8.5 Bibcol Recent Developments/Updates
6.9 PaxVax
6.9.1 PaxVax Corporation Information
6.9.2 PaxVax Description and Business Overview
6.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 PaxVax Oral Vaccines Product Portfolio
6.9.5 PaxVax Recent Developments/Updates
6.10 Vabiotech
6.10.1 Vabiotech Corporation Information
6.10.2 Vabiotech Description and Business Overview
6.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Vabiotech Oral Vaccines Product Portfolio
6.10.5 Vabiotech Recent Developments/Updates
6.11 Tiantan Biological
6.11.1 Tiantan Biological Corporation Information
6.11.2 Tiantan Biological Oral Vaccines Description and Business Overview
6.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Tiantan Biological Oral Vaccines Product Portfolio
6.11.5 Tiantan Biological Recent Developments/Updates
6.12 EuBiologics
6.12.1 EuBiologics Corporation Information
6.12.2 EuBiologics Oral Vaccines Description and Business Overview
6.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 EuBiologics Oral Vaccines Product Portfolio
6.12.5 EuBiologics Recent Developments/Updates
6.13 Panacea Biotec Ltd
6.13.1 Panacea Biotec Ltd Corporation Information
6.13.2 Panacea Biotec Ltd Oral Vaccines Description and Business Overview
6.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
6.13.5 Panacea Biotec Ltd Recent Developments/Updates
6.14 Bio-Med
6.14.1 Bio-Med Corporation Information
6.14.2 Bio-Med Oral Vaccines Description and Business Overview
6.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bio-Med Oral Vaccines Product Portfolio
6.14.5 Bio-Med Recent Developments/Updates
6.15 Halfkin Bio-Pharmaceuticals
6.15.1 Halfkin Bio-Pharmaceuticals Corporation Information
6.15.2 Halfkin Bio-Pharmaceuticals Oral Vaccines Description and Business Overview
6.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Vaccines Industry Chain Analysis
7.2 Oral Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Vaccines Production Mode & Process
7.4 Oral Vaccines Sales and Marketing
7.4.1 Oral Vaccines Sales Channels
7.4.2 Oral Vaccines Distributors
7.5 Oral Vaccines Customers
8 Oral Vaccines Market Dynamics
8.1 Oral Vaccines Industry Trends
8.2 Oral Vaccines Market Drivers
8.3 Oral Vaccines Market Challenges
8.4 Oral Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Oral Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oral Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Oral Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oral Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Oral Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oral Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oral Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oral Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oral Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Oral Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oral Vaccines Sales by Region (2019-2024) & (K Units)
Table 18. Global Oral Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Oral Vaccines Sales by Region (2025-2030) & (K Units)
Table 20. Global Oral Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Oral Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oral Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Oral Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oral Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Oral Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oral Vaccines Sales by Country (2019-2024) & (K Units)
Table 27. North America Oral Vaccines Sales by Country (2025-2030) & (K Units)
Table 28. North America Oral Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oral Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oral Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oral Vaccines Sales by Country (2019-2024) & (K Units)
Table 32. Europe Oral Vaccines Sales by Country (2025-2030) & (K Units)
Table 33. Europe Oral Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oral Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oral Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oral Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Oral Vaccines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Oral Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oral Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oral Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Oral Vaccines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Oral Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oral Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Oral Vaccines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Oral Vaccines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Oral Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oral Vaccines Sales (K Units) by Type (2019-2024)
Table 51. Global Oral Vaccines Sales (K Units) by Type (2025-2030)
Table 52. Global Oral Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Oral Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Oral Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oral Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oral Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Oral Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Oral Vaccines Price (USD/Unit) by Type (2019-2024)
Table 59. Global Oral Vaccines Price (USD/Unit) by Type (2025-2030)
Table 60. Global Oral Vaccines Sales (K Units) by Application (2019-2024)
Table 61. Global Oral Vaccines Sales (K Units) by Application (2025-2030)
Table 62. Global Oral Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Oral Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Oral Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oral Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oral Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Oral Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Oral Vaccines Price (USD/Unit) by Application (2019-2024)
Table 69. Global Oral Vaccines Price (USD/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Merck Oral Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. GSK Oral Vaccines Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Sanofi Oral Vaccines Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Lanzhou Institute Corporation Information
Table 86. Lanzhou Institute Description and Business Overview
Table 87. Lanzhou Institute Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Lanzhou Institute Oral Vaccines Product
Table 89. Lanzhou Institute Recent Developments/Updates
Table 90. Serum Institute Corporation Information
Table 91. Serum Institute Description and Business Overview
Table 92. Serum Institute Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Serum Institute Oral Vaccines Product
Table 94. Serum Institute Recent Developments/Updates
Table 95. Valneva Corporation Information
Table 96. Valneva Description and Business Overview
Table 97. Valneva Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Valneva Oral Vaccines Product
Table 99. Valneva Recent Developments/Updates
Table 100. Shanghai United Cell Corporation Information
Table 101. Shanghai United Cell Description and Business Overview
Table 102. Shanghai United Cell Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Shanghai United Cell Oral Vaccines Product
Table 104. Shanghai United Cell Recent Developments/Updates
Table 105. Bibcol Corporation Information
Table 106. Bibcol Description and Business Overview
Table 107. Bibcol Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Bibcol Oral Vaccines Product
Table 109. Bibcol Recent Developments/Updates
Table 110. PaxVax Corporation Information
Table 111. PaxVax Description and Business Overview
Table 112. PaxVax Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. PaxVax Oral Vaccines Product
Table 114. PaxVax Recent Developments/Updates
Table 115. Vabiotech Corporation Information
Table 116. Vabiotech Description and Business Overview
Table 117. Vabiotech Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Vabiotech Oral Vaccines Product
Table 119. Vabiotech Recent Developments/Updates
Table 120. Tiantan Biological Corporation Information
Table 121. Tiantan Biological Description and Business Overview
Table 122. Tiantan Biological Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Tiantan Biological Oral Vaccines Product
Table 124. Tiantan Biological Recent Developments/Updates
Table 125. EuBiologics Corporation Information
Table 126. EuBiologics Description and Business Overview
Table 127. EuBiologics Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. EuBiologics Oral Vaccines Product
Table 129. EuBiologics Recent Developments/Updates
Table 130. Panacea Biotec Ltd Corporation Information
Table 131. Panacea Biotec Ltd Description and Business Overview
Table 132. Panacea Biotec Ltd Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Panacea Biotec Ltd Oral Vaccines Product
Table 134. Panacea Biotec Ltd Recent Developments/Updates
Table 135. Bio-Med Corporation Information
Table 136. Bio-Med Description and Business Overview
Table 137. Bio-Med Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Bio-Med Oral Vaccines Product
Table 139. Bio-Med Recent Developments/Updates
Table 140. Halfkin Bio-Pharmaceuticals Corporation Information
Table 141. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 142. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Halfkin Bio-Pharmaceuticals Oral Vaccines Product
Table 144. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Oral Vaccines Distributors List
Table 148. Oral Vaccines Customers List
Table 149. Oral Vaccines Market Trends
Table 150. Oral Vaccines Market Drivers
Table 151. Oral Vaccines Market Challenges
Table 152. Oral Vaccines Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Vaccines
Figure 2. Global Oral Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oral Vaccines Market Share by Type in 2023 & 2030
Figure 4. Rotavirus Vaccine Product Picture
Figure 5. Cholera Vaccine Product Picture
Figure 6. Oral Polio Vaccine Product Picture
Figure 7. Global Oral Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Oral Vaccines Market Share by Application in 2023 & 2030
Figure 9. Public
Figure 10. Private
Figure 11. Global Oral Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Oral Vaccines Market Size (2019-2030) & (US$ Million)
Figure 13. Global Oral Vaccines Sales (2019-2030) & (K Units)
Figure 14. Global Oral Vaccines Average Price (USD/Unit) & (2019-2030)
Figure 15. Oral Vaccines Report Years Considered
Figure 16. Oral Vaccines Sales Share by Manufacturers in 2023
Figure 17. Global Oral Vaccines Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Oral Vaccines Players: Market Share by Revenue in 2023
Figure 19. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Oral Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 22. North America Oral Vaccines Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 26. Europe Oral Vaccines Revenue Market Share by Country (2019-2030)
Figure 27. Germany Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Oral Vaccines Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Oral Vaccines Revenue Market Share by Region (2019-2030)
Figure 34. China Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 45. Latin America Oral Vaccines Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Oral Vaccines Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Oral Vaccines by Type (2019-2030)
Figure 55. Global Revenue Market Share of Oral Vaccines by Type (2019-2030)
Figure 56. Global Oral Vaccines Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Oral Vaccines by Application (2019-2030)
Figure 58. Global Revenue Market Share of Oral Vaccines by Application (2019-2030)
Figure 59. Global Oral Vaccines Price (USD/Unit) by Application (2019-2030)
Figure 60. Oral Vaccines Value Chain
Figure 61. Oral Vaccines Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Oral Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Oral Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Oral Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Oral Vaccines Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Oral Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Oral Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Oral Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Oral Vaccines Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Oral Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Oral Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Oral Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Oral Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Oral Vaccines Sales by Region (2019-2024) & (K Units)
Table 18. Global Oral Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Oral Vaccines Sales by Region (2025-2030) & (K Units)
Table 20. Global Oral Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Oral Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Oral Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Oral Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Oral Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Oral Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Oral Vaccines Sales by Country (2019-2024) & (K Units)
Table 27. North America Oral Vaccines Sales by Country (2025-2030) & (K Units)
Table 28. North America Oral Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Oral Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Oral Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Oral Vaccines Sales by Country (2019-2024) & (K Units)
Table 32. Europe Oral Vaccines Sales by Country (2025-2030) & (K Units)
Table 33. Europe Oral Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Oral Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Oral Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Oral Vaccines Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Oral Vaccines Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Oral Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Oral Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Oral Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Oral Vaccines Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Oral Vaccines Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Oral Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Oral Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Oral Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Oral Vaccines Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Oral Vaccines Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Oral Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Oral Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Oral Vaccines Sales (K Units) by Type (2019-2024)
Table 51. Global Oral Vaccines Sales (K Units) by Type (2025-2030)
Table 52. Global Oral Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Oral Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Oral Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Oral Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Oral Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Oral Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Oral Vaccines Price (USD/Unit) by Type (2019-2024)
Table 59. Global Oral Vaccines Price (USD/Unit) by Type (2025-2030)
Table 60. Global Oral Vaccines Sales (K Units) by Application (2019-2024)
Table 61. Global Oral Vaccines Sales (K Units) by Application (2025-2030)
Table 62. Global Oral Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Oral Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Oral Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Oral Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Oral Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Oral Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Oral Vaccines Price (USD/Unit) by Application (2019-2024)
Table 69. Global Oral Vaccines Price (USD/Unit) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Merck Oral Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. GSK Oral Vaccines Product
Table 79. GSK Recent Developments/Updates
Table 80. Sanofi Corporation Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Sanofi Oral Vaccines Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Lanzhou Institute Corporation Information
Table 86. Lanzhou Institute Description and Business Overview
Table 87. Lanzhou Institute Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Lanzhou Institute Oral Vaccines Product
Table 89. Lanzhou Institute Recent Developments/Updates
Table 90. Serum Institute Corporation Information
Table 91. Serum Institute Description and Business Overview
Table 92. Serum Institute Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Serum Institute Oral Vaccines Product
Table 94. Serum Institute Recent Developments/Updates
Table 95. Valneva Corporation Information
Table 96. Valneva Description and Business Overview
Table 97. Valneva Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Valneva Oral Vaccines Product
Table 99. Valneva Recent Developments/Updates
Table 100. Shanghai United Cell Corporation Information
Table 101. Shanghai United Cell Description and Business Overview
Table 102. Shanghai United Cell Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Shanghai United Cell Oral Vaccines Product
Table 104. Shanghai United Cell Recent Developments/Updates
Table 105. Bibcol Corporation Information
Table 106. Bibcol Description and Business Overview
Table 107. Bibcol Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Bibcol Oral Vaccines Product
Table 109. Bibcol Recent Developments/Updates
Table 110. PaxVax Corporation Information
Table 111. PaxVax Description and Business Overview
Table 112. PaxVax Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. PaxVax Oral Vaccines Product
Table 114. PaxVax Recent Developments/Updates
Table 115. Vabiotech Corporation Information
Table 116. Vabiotech Description and Business Overview
Table 117. Vabiotech Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Vabiotech Oral Vaccines Product
Table 119. Vabiotech Recent Developments/Updates
Table 120. Tiantan Biological Corporation Information
Table 121. Tiantan Biological Description and Business Overview
Table 122. Tiantan Biological Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Tiantan Biological Oral Vaccines Product
Table 124. Tiantan Biological Recent Developments/Updates
Table 125. EuBiologics Corporation Information
Table 126. EuBiologics Description and Business Overview
Table 127. EuBiologics Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. EuBiologics Oral Vaccines Product
Table 129. EuBiologics Recent Developments/Updates
Table 130. Panacea Biotec Ltd Corporation Information
Table 131. Panacea Biotec Ltd Description and Business Overview
Table 132. Panacea Biotec Ltd Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Panacea Biotec Ltd Oral Vaccines Product
Table 134. Panacea Biotec Ltd Recent Developments/Updates
Table 135. Bio-Med Corporation Information
Table 136. Bio-Med Description and Business Overview
Table 137. Bio-Med Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Bio-Med Oral Vaccines Product
Table 139. Bio-Med Recent Developments/Updates
Table 140. Halfkin Bio-Pharmaceuticals Corporation Information
Table 141. Halfkin Bio-Pharmaceuticals Description and Business Overview
Table 142. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Halfkin Bio-Pharmaceuticals Oral Vaccines Product
Table 144. Halfkin Bio-Pharmaceuticals Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Oral Vaccines Distributors List
Table 148. Oral Vaccines Customers List
Table 149. Oral Vaccines Market Trends
Table 150. Oral Vaccines Market Drivers
Table 151. Oral Vaccines Market Challenges
Table 152. Oral Vaccines Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Oral Vaccines
Figure 2. Global Oral Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Oral Vaccines Market Share by Type in 2023 & 2030
Figure 4. Rotavirus Vaccine Product Picture
Figure 5. Cholera Vaccine Product Picture
Figure 6. Oral Polio Vaccine Product Picture
Figure 7. Global Oral Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Oral Vaccines Market Share by Application in 2023 & 2030
Figure 9. Public
Figure 10. Private
Figure 11. Global Oral Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Oral Vaccines Market Size (2019-2030) & (US$ Million)
Figure 13. Global Oral Vaccines Sales (2019-2030) & (K Units)
Figure 14. Global Oral Vaccines Average Price (USD/Unit) & (2019-2030)
Figure 15. Oral Vaccines Report Years Considered
Figure 16. Oral Vaccines Sales Share by Manufacturers in 2023
Figure 17. Global Oral Vaccines Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Oral Vaccines Players: Market Share by Revenue in 2023
Figure 19. Oral Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Oral Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 22. North America Oral Vaccines Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 26. Europe Oral Vaccines Revenue Market Share by Country (2019-2030)
Figure 27. Germany Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Oral Vaccines Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Oral Vaccines Revenue Market Share by Region (2019-2030)
Figure 34. China Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 45. Latin America Oral Vaccines Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Oral Vaccines Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Oral Vaccines Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Oral Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Oral Vaccines by Type (2019-2030)
Figure 55. Global Revenue Market Share of Oral Vaccines by Type (2019-2030)
Figure 56. Global Oral Vaccines Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Oral Vaccines by Application (2019-2030)
Figure 58. Global Revenue Market Share of Oral Vaccines by Application (2019-2030)
Figure 59. Global Oral Vaccines Price (USD/Unit) by Application (2019-2030)
Figure 60. Oral Vaccines Value Chain
Figure 61. Oral Vaccines Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232